• Oligonucleotide Networking Day - Frankfurt, October 28th

    Oligonucleotide Networking Day
    Frankfurt, October 28th

  • Understanding science, discovering

    Understanding science and discovering

  • Developing and marketing innovative solutions

    Developing and marketing innovative solutions

  • Manufacturing and supply

    Manufacturing and supply

    Tools content (print, share, increase/decrease text size):

     

    Middle area:

    Innovative and experienced R&D

    Sanofi: committed to innovation

    Sanofi is focused on answering patients’ unmet needs, which naturally leads to innovation. The R&D pipeline reflects this strong commitment:

    • About 60% are “New Molecular Entities” (NME)
    • 53% of these products are Biologics and Vaccines
     

    Going forward, Sanofi is continuously scouting for partnering opportunities from different sources (Universities, Biotech companies, Research Centres, Specialty Pharmaceutical companies) who share an innovative spirit.

     

    A partnership culture

    Sanofi has demonstrated its ability to set up mutually beneficial partnerships with both private and public companies and institutions through numerous alliances around the world. Currently, more than a quarter of the compounds in the Sanofi's R&D portfolio come from external partnerships.

     

    Furthermore, with a wide diversity of talents dedicated to R&D on more than 20 sites throughout the world, the Sanofi Group has developed a strong multicultural network of renowned experts.

     

    Extensive knowledge of health authority requirements

    In today’s dynamic and increasingly challenging healthcare environment, the registration of innovative products has become extremely complicated. Our experts are experienced in complex development programs and have developed strong and sustained relationships with scientific networks worldwide, ensuring that Sanofi is well placed to successfully develop innovative products.

     

     

    Dr. Maya R. Said
    Vice President Strategy, Science Policy & External Innovation, Global R&D
     

     
     

    To find out more about our R&D, visit the section:

     

    Right area:

    Partners to your ideas - Submit your project
     
    Available opportunities - Out-licensing
     

    Upcoming events

    American Diabetes Association (ADA) 73rd Scientific Sessions 2013

    June 21-25, 2013
    Chicago, IL, United States - USA

     
     

    © Sanofi 2004-2014 - All rights reserved - Update: September 04, 2014

    • Site complies with W3C WCAG 2.0 (new window, in english)